Tampa, FL– Thirteen scientists at Moffitt Cancer Center received close to $5 million in Florida grants to support research into understanding what causes cancer and what will lead to personalized treatments. The awards from the Bankhead-Coley Cancer Research Program and James & Esther King Biomedical Research Program will also fund research into patient outcomes and survival trends.
The peer-reviewed grants include the following projects:
- $1,000,000 to Dr. Dmitry Gabrilovich to look at how the body’s immune system reacts to tobacco and cancer.
- $1,000,000 to W. Jackson Pledger, Ph.D., to understand how lung cancer grows and develops.
- $375,000 to Matthew Schabath, Ph.D. , to study the genetic influence for lung cancer survival and outcomes.
- $375,000 to Erin Siegel, Ph.D. , to evaluate specific indicators for detecting colorectal cancer.
- $375,000 to Keiran Smalley, Ph.D. , to understand the role a specific gene plays in melanoma development.
- $374,998 to Masayuki Kanai, Ph.D., to understand the genetic causes for cell division and growth.
- $365,908 to David Evans, Ph.D., to examine how specific genes may contribute to nicotine-induced reduction of attention deficits.
- $200,000 to Alvaro Monteiro, Ph.D., to determine if the presence of a breast cancer gene affects outcomes in lung cancer.
- $200,000 to Dr. Esteban Celis, to develop a protein-based vaccine to treat melanoma.
- $200,000 to Srikumar Chellappan, Ph.D., to examine a specific gene’s role in non-small cell lung cancer growth and metastasis.
- $200,000 to Dr. Eduardo Sotomayor, to understand strategies for developing effective immunotherapy vaccines to treat B-cell lymphomas.
- $173,000 to Dr. Javier Torres-Roca to develop a test to predict sensitivity to radiation when treating prostate cancer.
- $137,500 to Dr. Jin Cheng, to study the role a family of genes plays in the growth and spread of breast cancer.
About H. Lee Moffitt Cancer Center & Research Institute
Located in Tampa, Florida, Moffitt Cancer Center is an NCI Comprehensive Cancer Center - a designation that recognizes Moffitt’s excellence in research and contributions to clinical trials, prevention and cancer control. Moffitt currently has 15 affiliates in Florida, one in Georgia and two in Puerto Rico. Additionally, Moffitt is a member of the National Comprehensive Cancer Network, a prestigious alliance of the country’s leading cancer centers, and is listed in U.S. News & World Report as one of “America’s Best Hospitals” for cancer. Moffitt’s sole mission is to contribute to the prevention and cure of cancer.